Abionic SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abionic SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10381
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abionic SA (Abionic) is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for android, iPhone and iPad, and accessories, among others. Its abioSCOPE in vitro tests are designed to deliver specific, semi-quantitative and personalized information about patients’ allergen sensitization at the point ofcare. Abionic offers abioGUIDE which application allows the user to see the results from the abioSCOPE directly on mobile platform. The company’s IVD capsule test offers accurate information about your patients’ respiratory allergies from a drop of blood. Its AbioGUIDE offers access to a complete database, showing cross-reactions with other allergens, as well as illustrations. Abionic is headquartered in Lausanne, Switzerland.

Abionic SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abionic SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abionic SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abionic SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abionic SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abionic SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abionic SA, Medical Equipment, Deal Details 10
Venture Financing 10
Abionic Raises USD21.1 Million in Series C Financing 10
Abionic Raises USD4 Million in Series B Venture Financing 11
Abionic Raises US$2 Million In First Financing Round 12
Partnerships 13
Lascco Enters into Partnership with Abionic 13
Abionic SA – Key Competitors 14
Abionic SA – Key Employees 15
Abionic SA – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Dec 06, 2017: Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Abionic SA, Medical Equipment, Key Facts 2
Abionic SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abionic SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abionic SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abionic SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abionic SA, Deals By Market, 2012 to YTD 2018 8
Abionic SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abionic Raises USD21.1 Million in Series C Financing 10
Abionic Raises USD4 Million in Series B Venture Financing 11
Abionic Raises US$2 Million In First Financing Round 12
Lascco Enters into Partnership with Abionic 13
Abionic SA, Key Competitors 14
Abionic SA, Key Employees 15

List of Figures
Abionic SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abionic SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abionic SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abionic SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abionic SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abionic SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abionic SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abionic SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abionic SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aclara Technologies LLC-エネルギー分野:企業M&A・提携分析
    Summary Aclara Technologies LLC (Aclara), as a subsidiary of Sun Capital Partners, Inc. The company designs, develops and commercializes Advanced Metering Infrastructure (AMI) solutions for data value management, customer communication and device networking activities. It provides an array of custom …
  • Georgia Power Co:発電所・企業SWOT分析
    Georgia Power Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Talanx AG:企業の戦略・SWOT・財務情報
    Talanx AG - Strategy, SWOT and Corporate Finance Report Summary Talanx AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Acuity Brands Inc (AYI):企業の財務・戦略的SWOT分析
    Acuity Brands Inc (AYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …
  • Mamee-Double Decker (M) Berhad:企業の戦略的SWOT分析
    Mamee-Double Decker (M) Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Zoltek Corp:企業の戦略的SWOT分析
    Zoltek Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • CLP Holdings Limited:発電所・企業SWOT分析
    CLP Holdings Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employee …
  • Newrest Group International S.A.S:企業の戦略・SWOT・財務情報
    Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report Summary Newrest Group International S.A.S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aesculap Inc:企業の製品パイプライン分析2018
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • Gene Biotherapeutics Inc (CRXM):企業の財務・戦略的SWOT分析
    Gene Biotherapeutics Inc (CRXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …
  • Incanthera Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Incanthera Ltd (Incanthera) is a drug development and targeted cancer medicines company that discovers and develops novel treatments for solid tumours. The company's pipeline drug candidates include ICT01-2588, a vascular disrupting agent, based on the tumor-blasting technology; ICT03 – Es5, …
  • Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析
    Summary Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Ch …
  • Protalex Inc (PRTX)-製薬・医療分野:企業M&A・提携分析
    Summary Protalex Inc (Protalex) is a biopharmaceutical company that develops and offers drugs for autoimmune and inflammatory diseases. The company’s product includes PRTX-100, a formulation of staphylococcal protein A, which is an immune modulating protein produced by Staphylococcus aureus bacteria …
  • Yanchang Petroleum International Ltd (346):企業の財務・戦略的SWOT分析
    Yanchang Petroleum International Ltd (346) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • The Kyoto Hotel, Ltd.
    The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Kyoto Hotel, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • National Jewish Health-製薬・医療分野:企業M&A・提携分析
    Summary National Jewish Health (NJH), formerly National Jewish Medical and Research Center is a healthcare center that offers treatment of pulmonary, cardiac, immune and related disorders. The center offers services in the areas of allergy, asthma, cardiology, clinical immunology, COPD, environmenta …
  • Compal Electronics Inc (2324):企業の財務・戦略的SWOT分析
    Summary Compal Electronics Inc (Compal) is a manufacturer of notebook based personal computers, liquid crystal display (LCD) products and smart devices. The company offers products which include display, communication, ODM and OEM, digital media, smart devices and automotive electronics. It also off …
  • Immunicum AB (IMMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Immunicum AB (Immunicum) is a biopharmaceutical company that focuses on the development of immuno-oncology therapies for the treatment of solid tumors. The company’s lead development candidate, ilixadencel is in clinical trials for the treatment a range of solid tumors including hepatic cell …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆